UNIFESP
Welcome,         Profile    Billing    Logout  
 6 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bagatin, Edileia
NCT06716398: A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance Phase

Recruiting
N/A
60
RoW
Test product, Comparator product
Pierre Fabre Dermo Cosmetique
Acne
07/25
07/25
Jackowski, Andrea P
NCT05477901: Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)

Not yet recruiting
N/A
450
US, RoW
Supplemental cash transfer
New York State Psychiatric Institute, National Institute of Mental Health (NIMH)
Inflammation, HPA, CBCL, Family Relations
12/27
01/28
Diaz, Ricardo
NCT05779020: Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .

Active, not recruiting
3
1373
RoW
Quadrivalent Influenza Vaccine (split virion, inactivated), Trivalent Influenza Vaccine (split virion, inactivated) containing Influenza B virus - Victoria lineage, Trivalent Influenza Vaccine (split virion, inactivated) containing Influenza B virus - Yamagata lineage
Butantan Institute, Fundação Butantan
Influenza, Human
09/24
08/25
DOVETAIL, NCT06497465: Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

Not yet recruiting
3
150
RoW
Dolutegravir 50mg Tab, TIVICAY 50 mg, TIVICAY PD, Dolutegravir/Lamivudine 50 MG-300mg Oral Tablet [DOVATO], Dolutegravir plus Tenofovir disoproxil fumarate (TDF)/ lamivudine (3TC)
Johns Hopkins University, ViiV Healthcare
Tuberculosis, HIV
01/28
01/29
NCT05354024: Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine

Completed
2/3
4400
RoW
NDV-HXP-S 10μg, BNT162b2 30μg
Butantan Institute
Coronavirus Infections, Healthy
10/23
09/24
NCT05218356: Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19

Recruiting
2
130
RoW
Covidir injections, Experimental drug administration, Quantitative PCR SARS-CoV-2, IgM and IgG dosage, Screening Blood tests, Electrocardiogram, ECG, NEWS-2 score, WHO score, Physical examination, COVID-19-Related Symptoms assessment
Code Pharma
COVID-19
12/24
07/25
NCT06799650: Clinical Trial of Gammora® Plus Antiretroviral Treatment for HIV

Recruiting
2
40
RoW
Gammora®, Tenofovir, 3TC, Darunavir, Ritonavir
Federal University of São Paulo, Code Pharma
HIV Seropositivity
02/25
03/25
NCT06805656: Multi Interventional Approaches to Mitigate HIV Reservoirs Aiming the Sustained HIV Remission Without Antiretrovirals

Not yet recruiting
N/A
70
RoW
Maraviroc, Selzentry, Celsentri, Dolutegravir, Tivicay, Dendritic Cell Vaccine, DC Vaccine, Auranofin, Gold Salt, Sirtuin Histone deacetylase inhibitor, Nicotinamide
Federal University of São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico
Hiv, HIV I Infection
07/26
12/27
Guazzelli, Cristina
NCT04047875: Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant

Completed
4
114
RoW
Norethisterone 10mg/day, Primolut-Nor®, 10 mg/day, 1 pill per day, Placebo
University of Sao Paulo, Organon
Breakthrough Bleeding
05/23
05/23

Download Options